Gyre Therapeutics, Inc. GYRE Shares (Diluted)
Shares (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Gyre Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.
The official record: Gyre Therapeutics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Gyre Therapeutics, Inc.'s shares (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Gyre Therapeutics, Inc.'s shares (diluted)?
- Gyre Therapeutics, Inc. (GYRE) reported shares (diluted) of 91.3M in Q1 2026.
- How has Gyre Therapeutics, Inc.'s shares (diluted) changed year-over-year?
- Gyre Therapeutics, Inc.'s shares (diluted) decreased by 10.4% year-over-year, from 102M to 91.3M.
- What is the long-term trend for Gyre Therapeutics, Inc.'s shares (diluted)?
- Over 4 years (2021 to 2025), Gyre Therapeutics, Inc.'s shares (diluted) has grown at a 35.6% compound annual growth rate (CAGR), from 121.8M to 411.8M.
- What does shares (diluted) mean?
- The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.